EMERGENT BIOSOLUTIONS INC. Public Float
EMERGENT BIOSOLUTIONS INC. (EBS) had Public Float of $342.70 million as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $342.70M.
- 2024-06-30: Entity Public Float $360.70M.
- 2023-06-30: Entity Public Float $380.70M.
- 2022-06-30: Entity Public Float $1.50B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $342.70M 10-K · filed 2026-02-27 | |
| 2024-06-30 | $360.70M 10-K · filed 2025-03-04 | |
| 2023-06-30 | $380.70M 10-K · filed 2024-03-08 | |
| 2022-06-30 | $1.50B 10-K/A · filed 2023-12-11 | |
| 2021-06-30 | $3.40B 10-K · filed 2022-02-25 | |
| 2020-06-30 | $4.20B 10-K · filed 2021-02-19 | |
| 2019-06-30 | $2.50B 10-K · filed 2020-02-25 | |
| 2018-06-30 | $2.10B 10-K · filed 2019-02-22 | |
| 2017-06-30 | $1.10B 10-K · filed 2018-02-23 | |
| 2016-06-30 | $920.00M 10-K · filed 2017-02-28 | |
| 2015-06-30 | $1.00B 10-K · filed 2016-02-29 | |
| 2014-12-31 | $0.00 10-K · filed 2015-03-09 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $366.00M 10-K · filed 2014-03-10 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-03 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $367.00M 10-K · filed 2013-03-08 | $0.00 10-Q · filed 2012-08-03 |
| 2011-12-31 | $492.00M 10-Q · filed 2012-05-04 | |
| 2011-09-30 | $274.00M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $492.00M 10-K · filed 2012-03-09 | $274.00M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |